CUREIMMUNE Trademark

Trademark Overview

On Sunday, January 14, 2018, a trademark application was filed for CUREIMMUNE with the United States Patent and Trademark Office. The USPTO has given the CUREIMMUNE trademark a serial number of 87754772. The federal status of this trademark filing is REGISTERED as of Tuesday, September 14, 2021. This trademark is owned by CureImmune Therapeutics Inc.. The CUREIMMUNE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medical research; Research and development in the field of therapy for cancer and autoimmune diseases; Development of pharmaceutical preparations and medicines; Research and development of vaccines and medicines
cureimmune

General Information

Serial Number87754772
Word MarkCUREIMMUNE
Filing DateSunday, January 14, 2018
Status700 - REGISTERED
Status DateTuesday, September 14, 2021
Registration Number6486535
Registration DateTuesday, September 14, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 29, 2018

Trademark Statements

Goods and ServicesMedical research; Research and development in the field of therapy for cancer and autoimmune diseases; Development of pharmaceutical preparations and medicines; Research and development of vaccines and medicines
Pseudo MarkCURE IMMUNE

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, January 26, 2018
Primary Code042
First Use Anywhere DateFriday, July 23, 2021
First Use In Commerce DateFriday, July 23, 2021

Trademark Owner History

Party NameCureImmune Therapeutics Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressVancouver, BC V6P6T3
CA
Party NameCureImmune Therapeutics Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressVancouver, BC V6P6T3
CA
Party NameCureImmune Therapeutics Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressVancouver, BC V6P6T3
CA

Trademark Events

Event DateEvent Description
Tuesday, September 14, 2021REGISTERED-PRINCIPAL REGISTER
Tuesday, August 10, 2021NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, August 9, 2021ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, July 26, 2021STATEMENT OF USE PROCESSING COMPLETE
Sunday, July 25, 2021USE AMENDMENT FILED
Sunday, July 25, 2021TEAS STATEMENT OF USE RECEIVED
Wednesday, February 10, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 9, 2021EXTENSION 5 GRANTED
Saturday, January 23, 2021EXTENSION 5 FILED
Tuesday, February 9, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Saturday, January 23, 2021TEAS EXTENSION RECEIVED
Thursday, July 23, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 21, 2020EXTENSION 4 GRANTED
Tuesday, July 21, 2020EXTENSION 4 FILED
Tuesday, July 21, 2020TEAS EXTENSION RECEIVED
Thursday, January 23, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 21, 2020EXTENSION 3 GRANTED
Tuesday, January 21, 2020EXTENSION 3 FILED
Tuesday, January 21, 2020TEAS EXTENSION RECEIVED
Wednesday, July 24, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 22, 2019EXTENSION 2 GRANTED
Monday, July 22, 2019EXTENSION 2 FILED
Monday, July 22, 2019TEAS EXTENSION RECEIVED
Wednesday, January 16, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 14, 2019EXTENSION 1 GRANTED
Monday, January 14, 2019EXTENSION 1 FILED
Monday, January 14, 2019TEAS EXTENSION RECEIVED
Tuesday, July 24, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 29, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 29, 2018PUBLISHED FOR OPPOSITION
Wednesday, May 9, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, April 26, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, April 24, 2018ASSIGNED TO EXAMINER
Friday, January 26, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Wednesday, January 17, 2018NEW APPLICATION ENTERED IN TRAM

Related Keywords

cureimmune research development medicines pharmaceutical preparations vaccines diseases cancer field therapy